- Home
- GBDC vs PRGO Comparison
GBDC vs PRGO Comparison
Compare GBDC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBDC
- PRGO
- Stock Information
- Founded
- GBDC 2009
- PRGO 1887
- Country
- GBDC United States
- PRGO Ireland
- Employees
- GBDC N/A
- PRGO N/A
- Industry
- GBDC Finance: Consumer Services
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- GBDC Finance
- PRGO Health Care
- Exchange
- GBDC Nasdaq
- PRGO Nasdaq
- Market Cap
- GBDC 3.7B
- PRGO 3.1B
- IPO Year
- GBDC 2010
- PRGO 1991
- Fundamental
- Price
- GBDC $13.60
- PRGO $12.72
- Analyst Decision
- GBDC Buy
- PRGO Buy
- Analyst Count
- GBDC 3
- PRGO 4
- Target Price
- GBDC $15.00
- PRGO $22.50
- AVG Volume (30 Days)
- GBDC 1.5M
- PRGO 4.0M
- Earning Date
- GBDC 11-18-2025
- PRGO 11-05-2025
- Dividend Yield
- GBDC 11.83%
- PRGO 9.05%
- EPS Growth
- GBDC 4.12
- PRGO N/A
- EPS
- GBDC 1.42
- PRGO N/A
- Revenue
- GBDC $870,777,000.00
- PRGO $4,281,800,000.00
- Revenue This Year
- GBDC $23.63
- PRGO $2.12
- Revenue Next Year
- GBDC N/A
- PRGO $0.49
- P/E Ratio
- GBDC $9.55
- PRGO N/A
- Revenue Growth
- GBDC 20.16
- PRGO N/A
- 52 Week Low
- GBDC $12.68
- PRGO $12.64
- 52 Week High
- GBDC $16.01
- PRGO $30.93
- Technical
- Relative Strength Index (RSI)
- GBDC 38.76
- PRGO 10.18
- Support Level
- GBDC $13.44
- PRGO $14.12
- Resistance Level
- GBDC $14.14
- PRGO $14.50
- Average True Range (ATR)
- GBDC 0.23
- PRGO 0.62
- MACD
- GBDC -0.05
- PRGO -0.34
- Stochastic Oscillator
- GBDC 20.55
- PRGO 1.73
About GBDC Golub Capital BDC Inc.
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.